AI at FDA: Commissioner Marty Makary today announced an aggressive timeline to scale use of artificial intelligence internally across all FDA centers by June 30, following the completion of a pilot for scientific reviewers.
Biotech angst: Vinay Prasad, just named to lead FDA's Center for Biologics Evaluation and Research, could significantly raise the bar for drug approvals. That worries investors and startups, Dan Primack reports.
Mental health: Advocacy groups and experts are warning that the Trump administration's approach to mental health so far threatens to make problems worse, not better, Caitlin Owens reports.
